tiprankstipranks
3 Best Stocks to Buy Now, 6/16/2023, According to Top Analysts
Stock Analysis & Ideas

3 Best Stocks to Buy Now, 6/16/2023, According to Top Analysts

Which stocks are best to buy now? According to top Wall Street analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating today and has a significant upside as well.

Pick the best stocks and maximize your portfolio:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by top-ranking analysts.

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

Corebridge Financial (NYSE:CRBG) – Corebridge is a multinational financial services provider. Today, analyst John Barnidge of Piper Sandler maintained a Buy rating on the stock with a price target of $26. Overall, the consensus 12-month price target of all six top analysts who recently rated the stock a Buy, implies an upside of 40.63%.

Topgolf Callaway (NYSE:MODG– Callaway is a sports equipment manufacturing company. Today, B.Riley Financial analyst Eric Wold reaffirmed a Buy rating on the stock with a price target of $31. Overall, the consensus 12-month price target of the seven out of eight top analysts who recently rated the stock a Buy, implies an upside of nearly 68%.

Aldeyra Therapeutics (NASDAQ:ALDX– The company develops computational tools and software for drug discovery and materials science. Today, analyst Matthew Caufield of H.C. Wainwright maintained a Buy rating on the stock with a $15 price target. Overall, the consensus 12-month price target of all three top analysts who recently rated the stock a Buy, implies an upside of 68.6%.

Who are the Top Analysts?

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. See real-time analyst rankings and learn more about the performance of top analysts on TipRanks’ Top Wall Street Analysts page.

Disclosure

Related Articles
TheFlyOppenheimer pharmaceuticals analysts hold analyst/industry conference call
TheFlyAldeyra says FDA accepts reproxalap NDA, AbbVie deal expanded to $100M
TheFlyAldeyra resubmits topical ocular reproxalap NDA to FDA
Go Ad-Free with Our App